Fuz mRNA level was found downregulated in head-neck squamous cell carcinoma (HNSC) and lung adenocarcinoma (LUAD) tumor samples, and such downregulation contributes to a reduction of the overall survival probabilities in patients. This evidence concerns the gene FUZ and lung adenocarcinoma.